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The prevalence of metabolic syndrome is increasing worldwide 
[1,2] and is becoming a social and economic problem. Recent-
ly, the increasing prevalence of metabolic syndrome in Korea 
has also been reported based on the Korean National Health 
and Nutritional Survey (KNHANES) [3]. The age-adjusted 
prevalence of metabolic syndrome in adults aged ≥20 years in 
Korea increased significantly from 24.9% in 1998 to 31.3% in 
2007, and, of five individual metabolic syndrome components, 
the incidence of low high density lipoprotein cholesterol (HDL-
C) criteria increased the most over 10 years (13.8% of increas-
ing) [3]. Hypertriglyceridemia also showed a significant 4.9% 
increase during that period [3]. 
  Metabolic syndrome is an important risk factor for athero-
sclerosis [4]. It is a disease characterized by insulin resistance 
[5], and dyslipidemia is one of its important components [6]. 
However low density lipoprotein cholesterol (LDL-C) level is 
not included in the criteria of metabolic syndrome. Elevated 
LDL-C level is a major cause of coronary heart disease and oth-
er atherosclerotic disease and can provide additional informa-
tion for the future risk of atherosclerosis aside from metabolic 
syndrome [7].
  Lee et al. [8] defined dyslipidemia according to LDL-C level 
as well as triglyceride and HDL-C level and investigated the 
change of prevalence of dyslipidemia among Korean adults 
during 1998-2005 with KNHANES data. Considering the im-
portance of LDL-C for the risk of atherosclerosis, this study is 
very important in the view of public health in Korea. Dyslipid-
emia in this study is defined as total cholesterol ≥240 mg/dL, 
LDL-C ≥160 mg/dL, HDL-C <40 mg/dL, and triglyceride 
≥200 mg/dL. However, it is known that women have higher 
levels of HDL-C than men [9-11], and the definition of low 
HDL cholesterolemia in the criteria of metabolic syndrome is 
different in men and women according to National Cholester-
ol Education Program Adult Treatment Panel III (NCEP ATP 
III) [6], with an HDL-C level <50 mg/dL required for women. 
A relatively lower prevalence of dyslipidemia in the women in 
this study [8] compared to that of a previous report [3] despite 
adding a criterion for LDL-C to the requirements of dyslipid-
emia might be due to a lower cutoff level of low HDL choles-
terolemia in women. Based on the appropriate cutoff level of 
low HDL cholesterolemia for the prediction of a clinically im-
portant end-point such as coronary heart disease in the Kore-
an population, the sex difference in HDL-C level should be 
considered.
  Cardiovascular and cerebrovascular disease is the second 
most prevalent cause of death in Korea following malignancy 
[12], and the incidence of mortality from cardiovascular dis-
ease has persistently increased during recent years [12]. Con-
sidering that dyslipidemia is a major cause of such diseases, the 
study of Lee et al. [8] is important to understand the increas-
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ing tendency of dyslipidemia and the very low control rate of 
dyslipidemia in the Korean population and to support the need 
for an urgent health and medical policy plan to control dyslip-
idemia. 
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